abstract |
The present invention relates to a compound of formula (I) R d —C (O) —N (R e ) —R c —CH 2 —C (O) —N (R a ) (R b ) wherein R a to R e is as defined in the specification and claims) and the novel heteroarylacetamides and physiologically acceptable salts thereof. These compounds inhibit clotting factor Xa and can be used as drugs. |